These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
New York
|
11-2250488
|
|
(State of incorporation)
|
(IRS Employer Identification No.)
|
|
650 Liberty Avenue, Union, New Jersey 07083
|
||
(Address of principal executive offices) (Zip Code)
|
Yes [x] No [ ]
|
Yes [x] No [ ]
|
Large accelerated filer [x]
|
Accelerated filer [ ]
|
|
Non-accelerated filer [ ] (Do not check if a smaller reporting company)
|
Smaller reporting company [ ]
|
Yes [ ] No [x]
|
Class
|
Outstanding at November 30, 2013
|
|
Common Stock - $0.01 par value
|
212,927,245
|
PART I - FINANCIAL INFORMATION
|
||
PART II - OTHER INFORMATION
|
||
Certifications
|
November 30,
2013
|
March 2,
2013
|
|||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents
|
$ | 471,064 | $ | 564,971 | ||||
Short term investment securities
|
223,114 | 449,933 | ||||||
Merchandise inventories
|
2,881,561 | 2,466,214 | ||||||
Other current assets
|
478,865 | 386,367 | ||||||
Total current assets
|
4,054,604 | 3,867,485 | ||||||
Long term investment securities | 87,021 | 77,325 | ||||||
Property and equipment, net | 1,523,253 | 1,466,667 | ||||||
Goodwill | 486,279 | 483,518 | ||||||
Other assets | 393,332 | 384,957 | ||||||
Total assets
|
$ | 6,544,489 | $ | 6,279,952 | ||||
Liabilities and Shareholders' Equity | ||||||||
Current liabilities: | ||||||||
Accounts payable
|
$ | 1,145,281 | $ | 913,365 | ||||
Accrued expenses and other current liabilities
|
417,073 | 393,094 | ||||||
Merchandise credit and gift card liabilities
|
267,332 | 251,481 | ||||||
Current income taxes payable
|
3,674 | 77,270 | ||||||
Total current liabilities
|
1,833,360 | 1,635,210 | ||||||
Deferred rent and other liabilities | 493,845 | 484,868 | ||||||
Income taxes payable | 87,456 | 80,144 | ||||||
Total liabilities
|
2,414,661 | 2,200,222 | ||||||
Shareholders' equity: | ||||||||
Preferred stock - $0.01 par value; authorized - 1,000
shares; no shares issued or outstanding
|
- | - | ||||||
Common stock - $0.01 par value; authorized - 900,000 shares;
issued 334,914 and 332,696 shares, respectively;
outstanding 212,927 and 221,489 shares, respectively
|
3,349 | 3,327 | ||||||
Additional paid-in capital
|
1,658,082 | 1,540,451 | ||||||
Retained earnings
|
8,262,603 | 7,573,612 | ||||||
Treasury stock, at cost; 121,987 and 111,207 shares, respectively
|
(5,785,579 | ) | (5,033,340 | ) | ||||
Accumulated other comprehensive loss
|
(8,627 | ) | (4,320 | ) | ||||
Total shareholders' equity
|
4,129,828 | 4,079,730 | ||||||
Total liabilities and shareholders' equity
|
$ | 6,544,489 | $ | 6,279,952 |
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
November 30,
2013
|
November 24,
2012
|
November 30,
2013
|
November 24,
2012
|
|||||||||||||
Net sales
|
$ | 2,864,837 | $ | 2,701,801 | $ | 8,300,649 | $ | 7,513,108 | ||||||||
Cost of sales
|
1,743,147 | 1,627,791 | 5,032,504 | 4,519,230 | ||||||||||||
Gross profit
|
1,121,690 | 1,074,010 | 3,268,145 | 2,993,878 | ||||||||||||
Selling, general and administrative expenses
|
747,043 | 712,361 | 2,180,631 | 1,953,694 | ||||||||||||
Operating profit
|
374,647 | 361,649 | 1,087,514 | 1,040,184 | ||||||||||||
Interest income (expense), net
|
1,314 | (3,122 | ) | (586 | ) | (3,909 | ) | |||||||||
Earnings before provision for income taxes
|
375,961 | 358,527 | 1,086,928 | 1,036,275 | ||||||||||||
Provision for income taxes
|
138,764 | 125,777 | 397,937 | 372,359 | ||||||||||||
Net earnings
|
$ | 237,197 | $ | 232,750 | $ | 688,991 | $ | 663,916 | ||||||||
Net earnings per share - Basic
|
$ | 1.13 | $ | 1.04 | $ | 3.24 | $ | 2.93 | ||||||||
Net earnings per share - Diluted
|
$ | 1.12 | $ | 1.03 | $ | 3.20 | $ | 2.89 | ||||||||
Weighted average shares outstanding - Basic
|
209,704 | 223,687 | 212,430 | 226,362 | ||||||||||||
Weighted average shares outstanding - Diluted
|
212,315 | 226,661 | 215,116 | 229,551 |
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
November 30,
2013
|
November 24,
2012
|
November 30,
2013
|
November 24,
2012
|
|||||||||||||
Net earnings
|
$ | 237,197 | $ | 232,750 | $ | 688,991 | $ | 663,916 | ||||||||
Other comprehensive income (loss):
|
||||||||||||||||
Change in temporary impairment of auction
rate securities, net of taxes
|
280 | 622 | (608 | ) | 1,041 | |||||||||||
Pension adjustment, net of taxes
|
1,208 | 342 | 1,571 | 790 | ||||||||||||
Currency translation adjustment
|
(1,197 | ) | (73 | ) | (5,270 | ) | 906 | |||||||||
Other comprehensive income (loss)
|
291 | 891 | (4,307 | ) | 2,737 | |||||||||||
Comprehensive income
|
$ | 237,488 | $ | 233,641 | $ | 684,684 | $ | 666,653 |
Nine Months Ended
|
||||||||
November 30,
2013
|
November 24,
2012
|
|||||||
Cash Flows from Operating Activities: | ||||||||
Net earnings
|
$ | 688,991 | $ | 663,916 | ||||
Adjustments to reconcile net earnings to net cash
provided by operating activities:
|
||||||||
Depreciation
|
160,672 | 139,411 | ||||||
Stock-based compensation
|
42,078 | 34,591 | ||||||
Tax benefit from stock-based compensation
|
12,676 | 13,056 | ||||||
Deferred income taxes
|
6,275 | (13,897 | ) | |||||
Other
|
(1,007 | ) | 826 | |||||
Increase in assets, net of effect of acquisitions:
|
||||||||
Merchandise inventories
|
(415,347 | ) | (496,100 | ) | ||||
Trading investment securities
|
(10,702 | ) | (3,508 | ) | ||||
Other current assets
|
(101,907 | ) | (86,975 | ) | ||||
Other assets
|
(5,478 | ) | (10,655 | ) | ||||
Increase (decrease) in liabilities, net of effect of acquisitions:
|
||||||||
Accounts payable
|
244,761 | 292,305 | ||||||
Accrued expenses and other current liabilities
|
24,301 | 8,398 | ||||||
Merchandise credit and gift card liabilities
|
15,851 | 21,196 | ||||||
Income taxes payable
|
(66,284 | ) | 32,110 | |||||
Deferred rent and other liabilities
|
7,056 | 12,742 | ||||||
Net cash provided by operating activities
|
601,936 | 607,416 | ||||||
|
||||||||
Cash Flows from Investing Activities:
|
||||||||
Purchase of held-to-maturity investment securities
|
(682,339 | ) | (393,578 | ) | ||||
Redemption of held-to-maturity investment securities
|
909,375 | 1,031,249 | ||||||
Redemption of available-for-sale investment securities
|
- | 31,715 | ||||||
Capital expenditures
|
(228,928 | ) | (238,405 | ) | ||||
Investment in unconsolidated joint venture
|
(3,436 | ) | - | |||||
Payment for acquisitions, net of cash acquired
|
- | (643,098 | ) | |||||
Payment for acquisition of trademarks
|
- | (40,000 | ) | |||||
Net cash used in investing activities
|
(5,328 | ) | (252,117 | ) | ||||
Cash Flows from Financing Activities:
|
||||||||
Proceeds from exercise of stock options
|
54,431 | 31,660 | ||||||
Excess tax benefit from stock-based compensation
|
7,293 | 3,885 | ||||||
Payment for credit facility assumed in acquisition
|
- | (25,511 | ) | |||||
Repurchase of common stock, including fees
|
(752,239 | ) | (696,237 | ) | ||||
Net cash used in financing activities
|
(690,515 | ) | (686,203 | ) | ||||
Net decrease in cash and cash equivalents
|
(93,907 | ) | (330,904 | ) | ||||
Cash and cash equivalents:
|
||||||||
Beginning of period
|
564,971 | 1,003,166 | ||||||
End of period
|
$ | 471,064 | $ | 672,262 |
As of November 30, 2013
|
||||||||||||
(in millions)
|
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
|||||||||
Long term - available-for-sale securities:
|
||||||||||||
Auction rate securities
|
$ | - | $ | 48.0 | $ | 48.0 | ||||||
Long term - trading securities:
|
||||||||||||
Nonqualified deferred compensation plan assets
|
39.0 | - | 39.0 | |||||||||
Total
|
$ | 39.0 | $ | 48.0 | $ | 87.0 |
As of March 2, 2013 | ||||||||||||
(in millions)
|
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
|||||||||
Long term - available-for-sale securities:
|
||||||||||||
Auction rate securities
|
$ | - | $ | 49.0 | $ | 49.0 | ||||||
Long term - trading securities:
|
||||||||||||
Nonqualified deferred compensation plan assets
|
28.3 | - | 28.3 | |||||||||
Total
|
$ | 28.3 | $ | 49.0 | $ | 77.3 |
(in millions)
|
Auction Rate
Securities
|
|||
Balance on March 2, 2013, net of temporary valuation adjustment
|
$ | 49.0 | ||
Change in temporary valuation adjustment included in accumulated other comprehensive loss
|
(1.0 | ) | ||
Redemptions at par
|
- | |||
Balance on November 30, 2013, net of temporary valuation adjustment
|
$ | 48.0 |
(in millions)
|
November 30,
2013
|
March 2,
2013
|
||||||
Available-for-sale securities:
|
||||||||
Long term
|
$ | 48.0 | $ | 49.0 | ||||
Trading securities:
|
||||||||
Long term
|
39.0 | 28.3 | ||||||
Held-to-maturity securities:
|
||||||||
Short term
|
223.1 | 449.9 | ||||||
Total investment securities
|
$ | 310.1 | $ | 527.2 |
Nine Months Ended
|
||||||||
Black-Scholes Valuation Assumptions (1)
|
November 30,
2013
|
November 24,
2012
|
||||||
Weighted Average Expected Life (in years) (2)
|
6.6 | 6.5 | ||||||
Weighted Average Expected Volatility (3)
|
29.27 | % | 31.07 | % | ||||
Weighted Average Risk Free Interest Rates (4)
|
1.11 | % | 1.14 | % | ||||
Expected Dividend Yield
|
- | - |
(Shares in thousands)
|
Number of
Stock Options
|
Weighted Average
Exercise Price
|
||||||
Options outstanding, beginning of period
|
5,006 | $ | 42.32 | |||||
Granted
|
563 | 69.78 | ||||||
Exercised
|
(1,369 | ) | 39.75 | |||||
Forfeited or expired
|
(2 | ) | 38.30 | |||||
Options outstanding, end of period
|
4,198 | $ | 46.84 | |||||
Options exercisable, end of period
|
2,409 | $ | 39.11 |
(Shares in thousands)
|
Number of Restricted
Shares
|
Weighted Average
Grant-Date
Fair Value
|
||||||
Unvested restricted stock, beginning of period
|
4,063 | $ | 45.98 | |||||
Granted
|
975 | 69.77 | ||||||
Vested
|
(959 | ) | 38.36 | |||||
Forfeited
|
(126 | ) | 52.13 | |||||
Unvested restricted stock, end of period
|
3,953 | $ | 53.50 |
(in millions)
|
As of June 29, 2012
|
|||
Current assets
|
$ | 222.0 | ||
Property and equipment and other non-current assets
|
132.4 | |||
Intangible assets
|
211.6 | |||
Goodwill
|
247.4 | |||
Total assets acquired
|
813.4 | |||
Accounts payable and other liabilities
|
(252.9 | ) | ||
Borrowings under credit facility
|
(25.5 | ) | ||
Total liabilities acquired
|
(278.4 | ) | ||
Total net assets acquired
|
$ | 535.0 |
·
|
For the three and nine months ended November 30, 2013, the Company’s net sales were $2.865 billion and $8.301 billion, respectively, an increase of approximately 6.0% and 10.5%, respectively, as compared with the three and nine months ended November 24, 2012.
|
·
|
Comparable store sales for the fiscal third quarter of 2013 increased by approximately 1.3% as compared with an increase of approximately 1.7% for the corresponding period last year. For both the nine months ended November 30, 2013 and November 24, 2012, comparable store sales increased by approximately 2.7%.
A store is considered a comparable store when it has been open for twelve full months following its grand opening period (typically four to six weeks). Stores relocated or expanded are excluded from comparable store sales if the change in square footage would cause meaningful disparity in sales over the prior period. In the case of a store to be closed, such store’s sales are not considered comparable once the store closing process has commenced. Linen Holdings is excluded from the comparable store sales calculations and will continue to be excluded on an ongoing basis as it represents non-retail activity. World Market was excluded from the comparable store sales calculations through the end of the fiscal first half of 2013, and is included beginning with the fiscal third quarter of 2013.
|
·
|
Gross profit for the three months ended November 30, 2013 was $1.122 billion, or 39.2% of net sales, compared with $1.074 billion, or 39.8% of net sales, for the three months ended November 24, 2012. Gross profit for the nine months ended November 30, 2013 was $3.268 billion, or 39.4% of net sales, compared with $2.994 billion, or 39.8% of net sales, for the nine months ended November 24, 2012.
|
·
|
Selling, general and administrative expenses (“SG&A”) for the three months ended November 30, 2013 were $747.0 million, or 26.1% of net sales, compared with $712.4 million, or 26.4% of net sales, for the three months ended November 24, 2012. SG&A for the nine months ended November 30, 2013 were $2.181 billion, or 26.3% of net sales, compared with $1.954 billion, or 26.0% of net sales, for the nine months ended November 24, 2012.
|
·
|
The effective tax rate for the three months ended November 30, 2013 was 36.9% compared with 35.1% for the three months ended November 24, 2012. The effective tax rate for the nine months ended November 30, 2013 was 36.6% compared with 35.9% for the nine months ended November 24, 2012. The tax rate included discrete items of an approximate $4.9 million net benefit and $9.1 million net benefit, respectively, for the three months ended November 30, 2013 and November 24, 2012 and an approximate $17.2 million net benefit and $24.3 million net benefit, respectively, for the nine months ended November 30, 2013 and November 24, 2012.
|
·
|
For the three months ended November 30, 2013, net earnings per diluted share were $1.12 ($237.2 million), an increase of approximately 8.7%, as compared with net earnings per diluted share of $1.03 ($232.8 million) for the three months ended November 24, 2012. For the nine months ended November 30, 2013, net earnings per diluted share were $3.20 ($689.0 million), an increase of approximately 10.7%, as compared with net earnings per diluted share of $2.89 ($663.9 million) for the nine months ended November 24, 2012. The increases in net earnings per diluted share for the three and nine months ended November 30, 2013 are the result of the items described above, as well as the impact of the Company’s repurchases of its common stock.
|
Financial Reporting Calendar
|
|||||
Fiscal 2013 (fifty-two weeks)
|
Fiscal 2012 (fifty-three weeks)
|
||||
First Quarter
|
March 3, 2013 - June 1, 2013
|
February 26, 2012 - May 26, 2012
|
|||
Second Quarter
|
June 2, 2013 - August 31, 2013
|
May 27, 2012 - August 25, 2012
|
|||
Third Quarter
|
September 1, 2013 - November 30, 2013
|
August 26, 2012 - November 24, 2012
|
|||
Fourth Quarter
|
December 1, 2013 - March 1, 2014
|
November 25, 2012 - March 2, 2013
|
Comparable Store Sales Calendar
|
|||||
Fiscal 2013 (fifty-two weeks)
|
Fiscal 2012 (fifty-two weeks)
|
||||
First Quarter
|
March 3, 2013 - June 1, 2013
|
March 4, 2012 - June 2, 2012
|
|||
Second Quarter
|
June 2, 2013 - August 31, 2013
|
June 3, 2012 - September 1, 2012
|
|||
Third Quarter
|
September 1, 2013 - November 30, 2013
|
September 2, 2012 - December 1, 2012
|
|||
Fourth Quarter
|
December 1, 2013 - March 1, 2014
|
December 2, 2012 - March 2, 2013
|
(a)
|
Disclosure Controls and Procedures
|
(b)
|
Changes in Internal Control
over Financial Reporting
|
Approximate Dollar
|
||||||||||||||||
Total Number of
|
Value of Shares
|
|||||||||||||||
Shares Purchased as
|
that May Yet Be
|
|||||||||||||||
Part of Publicly
|
Purchased Under
|
|||||||||||||||
Total Number of
|
Average Price
|
Announced Plans
|
the Plans or
|
|||||||||||||
Period
|
Shares Purchased (1)
|
Paid per Share (2)
|
or Programs (1)
|
Programs (1) (2)
|
||||||||||||
September 1, 2013 - September 28, 2013
|
899,000 | $ | 73.84 | 899,000 | $ | 1,770,569,319 | ||||||||||
September 29, 2013 - October 26, 2013
|
684,500 | $ | 76.90 | 684,500 | $ | 1,717,928,129 | ||||||||||
October 27, 2013 - November 30, 2013
|
674,500 | $ | 76.99 | 674,500 | $ | 1,665,999,159 | ||||||||||
Total
|
2,258,000 | $ | 75.71 | 2,258,000 | $ | 1,665,999,159 |
(1) Between December 2004 and December 2012, the Company's Board of Directors authorized, through several share repurchase programs, the repurchase of $7.450 billion of its shares of common stock. The Company has authorization to make repurchases from time to time in the open market or through other parameters approved by the Board of Directors pursuant to existing rules and regulations. Shares purchased indicated in this table also include the withholding of a portion of restricted shares to cover taxes on vested restricted shares.
|
(2) Excludes brokerage commissions paid by the Company.
|
BED BATH & BEYOND INC.
|
||
(Registrant)
|
||
Date: January 8, 2014
|
By: |
/s/ Eugene A. Castagna
|
Eugene A. Castagna | ||
Chief Financial Officer and Treasurer | ||
(Principal Financial and Accounting Officer) |
Exhibit No. | Exhibit | |
31.1
|
Certification of Principal Executive Officer Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31.2
|
Certification of Principal Financial Officer Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32
|
Certification of Principal Executive Officer and Principal
Financial Officer Pursuant to 18 U.S.C. Section 1350, as
Adopted Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
|
|
101.INS | XBRL Instance Document | |
101.SCH | XBRL Taxonomy Extension Schema Document | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Suppliers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|